Re: This is ridiculous Antidepressants May Fight Colorectal Cancer

March 30, 2006

I can see how it could occur, if they weren't working

at jobs that caused cancer, when using the SSRIs.

But beyond that , SSRIs cant cure a damn thing.

SSRI drugs, cause disease .

When the colon slows down from SSRI use, its more prone

to cancer than to cure it .

SSRIs can cause constant constipation, or diareah.

There is nothing regular about using them.

This is to gain more converts .

Damn, what a cult Psychiatry/ Medical /Pharm is .

I know it causes this ..................

http://diabetes.niddk.nih.gov/dm/pubs/neuropathies/

jmc4angels <jmc4angels@...> wrote:

http://www.forbes.com/lifestyle/health/feeds/hscout/2006/03/27/hscout5

31788.html

Antidepressants May Fight Colorectal Cancer

03.27.06, 12:00 AM ET

MONDAY, March 27 (HealthDay News) -- A pioneering study supports a

theory that a widely used class of antidepressant drugs can also

fight cancers, such as colorectal cancer, Canadian researchers report.

The drugs, called selective serotonin reuptake inhibitors (SSRIs),

include such popular medications as Prozac, Paxil and Zoloft. The

study was based on reports that serotonin, the body chemical linked

to depression, also promotes the growth of cancer cells, said Dr.

Jean- Collet, professor of biostatistics and epidemiology at

McGill University in Montreal.

To test the validity of those reports, Collet and his colleagues

turned to an existing database of Saskatchewan residents enrolled in

a prescription drug plan. They found about a 30 percent lower

incidence of colorectal cancer among people who took high doses of

SSRIs, compared to those who did not take the drugs. No such

reduction was found in people taking the older class of tricyclical

antidepressants.

The results might apply to other cancers as well, Collet said, " but

we chose colorectal cancer because the colon is rich in serotonin. "

And while the results are very preliminary, he said the study had the

advantage of producing results in just six months.

" Now, even knowing the limitations of our study, it is a very strong

piece of information to identify how to conduct future studies to

validate the results, " he said.

The results appear in the April issue of the journal Lancet Oncology.

The study drew a measured response from Dr. Henrik Toft Sorensen,

professor of clinical epidemiology at Aarhus University in Denmark,

who wrote an accompanying editorial in the journal.

" It is an interesting paper, but the study needs to be replicated by

other groups, " Sorensen said. " I can't rule out that the results

might be due to bias. "

Until carefully controlled studies are done, " treatment of colorectal

cancer should not be changed, " he said.

Collet said: " The next step should be to study the effects of SSRIs

in high-risk populations, such as persons with a family history of

colorectal cancer, to see whether in this treatment we can find

protection. Also, studies might be done in patients who have cancer,

to see whether after surgery, we could reduce the rate of recurrence

or metastasis [spread of cancer elsewhere in the body]. "

Future studies would have to take into account such factors as diet,

use of other drugs and the presence of diseases such as diabetes and

inflammatory bowel disease, which can affect the risk of colorectal

cancer, the researchers wrote.

If studies do confirm the cancer-fighting effects of SSRIs, that

could boost sales of the already-popular drugs. About 100 million

SSRI prescriptions are written each year in the United States, and

the number of prescriptions in Canada rose from 3.2 million in 1981

to 14.5 million in 2000, the report said.

March 30, 2006